Circadian control of stress granules by oscillating EIF2α

Cell Death Dis. 2019 Mar 4;10(3):215. doi: 10.1038/s41419-019-1471-y.

Abstract

Stress granule formation is important for stress response in normal cells and could lead to chemotherapy resistance in cancer cells. Aberrant stress granule dynamics are also known to disrupt proteostasis, affect RNA metabolism, and contribute to neuronal cell death. Meanwhile, circadian abnormality is an aging-related risk factor for cancer and neurodegeneration. Whether stress granule dynamics are circadian regulated is entirely unknown. Here we show that the formation of stress granules varied by zeitgeber time in mouse liver. Moreover, altering circadian regulation by silencing the core circadian gene Bmal1 in a cell line expressing an endogenous GFP-tagged G3BP1 significantly increased stress granule dynamics, while the overexpression of Bmal1 decreased them. Surprisingly, increased stress granule dynamics and formation by transient decrease of BMAL1 coincided with increased resistance to stress-induced cell death. The circadian regulation of stress granules was mediated by oscillating eIF2α expression. At zeitgeber time when BMAL1 and eIF2α were at nadir, reduction of unphosphorylated eIF2α could significantly alter the ratio of phosphorylated/total eIF2α and quickly lead to increased formation of stress granules. Therefore, diurnal oscillating eIF2α connects the circadian cue to a cellular stress response mechanism that is vital for both neurodegeneration and cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ARNTL Transcription Factors / genetics
  • ARNTL Transcription Factors / metabolism
  • ARNTL Transcription Factors / physiology
  • Animals
  • Circadian Rhythm / genetics*
  • Drug Resistance, Neoplasm
  • Eukaryotic Initiation Factor-2 / metabolism
  • Eukaryotic Initiation Factor-2 / physiology*
  • Gene Expression Regulation
  • Male
  • Mice, Inbred C57BL
  • Stress, Physiological*

Substances

  • ARNTL Transcription Factors
  • Eukaryotic Initiation Factor-2